Inhalation Sciences Sweden AB

Inhalation research instruments and CRO services for preclinical pharma/biotech development.

ISAB | SPGR

Overview

Corporate Details

ISIN(s):: SE0009983893 (+2 more)
LEI:: 54930018BAFIJ0IXTL75
Country:: Sweden
Address:: C/O Kliniskt Forskningscentrum KFC, 141 57 Huddinge
Website:: https://www.inhalation.se/
Sector:: Professional, scientific and technical activities
Industry:: Research and experimental development on natural sciences and engineering

Description

Inhalation Sciences Sweden AB is a life sciences company specializing in inhalation research. The company develops and sells patented laboratory instruments and provides contract research organization (CRO) services. Its flagship technology, the PreciseInhale® platform, offers precise aerosol generation and exposure control, enabling detailed studies on how inhaled particles affect the respiratory system. This system provides high-quality data on dose-response relationships and regional lung deposition. Through its Inhalation Research Services, the company supports pharmaceutical and biotech clients in the preclinical development of orally inhaled and intra-nasal drug products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Inhalation Sciences Sweden AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Inhalation Sciences Sweden AB via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
FARON PHARMACEUTICALS OY Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.	Finland	FARN
Fluicell AB Developing bioprinted tissues for regenerative medicine and advanced drug screening.	Sweden	FLUI
FluoGuide A/S Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.	Denmark	FLUO
FUSION ANTIBODIES PLC A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.	United Kingdom	FAB
FUTURA MEDICAL PLC Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.	United Kingdom	FUM
GENINCODE PLC AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.	United Kingdom	GENI
Genomic Vision Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.	France	GV
Genxone Spolka Akcyjna A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.	Poland	GX1
Hamlet BioPharma AB Developing selective therapies for cancer and infections like bladder cancer and UTIs.	Sweden	HAMLET
Hipower Energy Spolka Akcyjna Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.	Poland	HPE